PLK1 Inhibition by Volasertib Suppresses Key Transcriptional Regulators Underlying Fibroblast Activation and Pulmonary Fibrosis

PLK1 Inhibition by Volasertib Suppresses Key Transcriptional Regulators Underlying Fibroblast Activation and Pulmonary Fibrosis | ReachRx